FITB vs RANI · P/E 17, rev $3.37B vs rev $3.4M
Fifth Third Bancorp (FITB) versus Rani Therapeutics Holdings Inc (RANI) — a side-by-side from cached financials, not a winner call.
Fifth Third Bancorp (FITB) is a banks - regional company listed on US.
Rani Therapeutics Holdings Inc (RANI) is a biotechnology company listed on US.
Latest reported FITB revenue for 2026-06-30 was $3.37B. Net income was $801.0M. Revenue was up 13.5% from 2026-03-31 to 2026-06-30. FITB currently screens at market cap $45.25B and trailing P/E 16.8.
Latest reported RANI revenue for 2026-06-30 was $3.4M. Net income was -$14.4M. Revenue was up 100.0% from 2026-03-31 to 2026-06-30. RANI currently screens at market cap $41.5M.
FITB currently screens at market cap $45.25B and trailing P/E 16.8. RANI currently screens at market cap $41.5M.
Not investment advice. Open the FITB and RANI stock pages for the full models.
Not investment advice.